Finance
Markets

BMY

stock NYSE
Bristol-Myers Squibb Company
$59.55 +1.01 (+1.73%) At close

Key stats

The day open and close within the day's range
Low $57.83 High $59.61
Open
$58.23
-0.53%
Close
$59.55
+1.73%
52-week range where the price sits across its year
52w low $42.52 52w high $62.89
Current
$59.55
Prev close
$58.54
Volume 0.73× the 3-month average
0 avg 2× avg
Today
8.45M
3-mo avg
11.64M

Fundamentals

Each ratio reads FY2025 figures against the latest price, graded so the quality shows at a glance.

P/E ratio Strong
17.2x

At 17x, the price is a reasonable multiple of the company's annual profit.

Share price divided by earnings per share: what you pay for each $1 of yearly profit. Roughly 15 to 25 is typical, above 40 is richly priced, and negative means the company is losing money.

Dividend yield Strong
4.18%

A 4.2% yield is a healthy, generally sustainable level of cash income.

The yearly dividend as a percent of the share price: the cash income each share pays out. Around 2 to 6% is healthy; above roughly 8% often signals the payout may be cut.

Profit margin Fair
14.6%

A 14.6% margin is solid, in the ordinary range for a profitable company.

The share of revenue left as profit once every cost is paid. Above 15% is strong; below 5% leaves little cushion against a bad year.

Return on equity Strong
38.2%

A 38.2% return on equity is strong; the company compounds owners' capital well.

Profit earned on each dollar of shareholder equity: how well the company compounds its owners' capital. Above 15% is strong.

Return on assets Fair
7.8%

A 7.8% return on assets is reasonable for a company of this kind.

Profit earned on each dollar of assets: how efficiently the whole asset base is used. Above 8% is strong.

Debt-to-equity Weak
3.87

At 3.87, the company leans heavily on borrowing, which adds risk if results weaken.

Total liabilities divided by shareholder equity: how heavily the company leans on borrowing. Below 1 is conservative; above 2 is highly leveraged.

Current ratio Fair
1.26

At 1.26, short-term assets cover short-term bills with a little room to spare.

Current assets divided by current liabilities: whether short-term resources cover short-term bills. Above 1.5 is comfortable; below 1 is tight.

Revenue growth Weak
-0.2%

Revenue fell 0.2% from the prior year; the top line is contracting.

Change in annual revenue from the prior fiscal year: whether the top line is expanding. Above 10% is strong growth; below 0 means revenue is shrinking.

Earnings growth No data
·

The company returned to profit after a loss-making prior year.

Change in annual net income from the prior fiscal year: whether profit is expanding. Above 10% is strong; below 0 means profit is falling.

Financials

FY2021FY2022FY2023FY2024FY2025
Revenue $46.4B$46.2B$45.0B$48.3B$48.2B
Net income $7.0B$6.3B$8.0B-$8.9B$7.1B
Diluted EPS $3.12$2.95$3.86$-4.41$3.46
Dividend / share $2.01$2.19$2.31$2.42$2.49
Total assets $109.3B$96.8B$95.2B$92.6B$90.0B
Total liabilities $73.3B$65.7B$65.7B$76.2B$71.5B
Shareholder equity $35.9B$31.1B$29.4B$16.3B$18.5B

Recent SEC filings